Thierry Guetta

Clinique Ambroise Paré

Papers

1

Total Citations

7

H-Index

1

About

Thierry Guetta is a leading researcher in the intersection of oncology, surgical robotics, and health economics, with a primary focus on prostate cancer treatment. His most cited work, a 2022 cost-utility analysis, provides a groundbreaking comparison between robot-assisted radical prostatectomies (rRP) and robot-assisted stereotactic body radiotherapy (rSBRT) for prostate cancer, the most common cancer among men in France. By evaluating both clinical outcomes and economic impacts, Guetta’s research offers critical insights into optimizing treatment pathways, helping clinicians and policymakers balance efficacy with cost-effectiveness. With 7 citations, this study underscores his role in advancing precision oncology and robotic surgery applications. Beyond this, Guetta’s contributions extend to improving patient-centered care, demonstrating how technological innovations can be integrated into real-world healthcare systems. His work is particularly notable for bridging the gap between cutting-edge medical technology and practical, value-based decision-making. For students and researchers, Guetta exemplifies how rigorous economic modeling can shape the future of cancer treatment, making his profile a compelling study in translational research and health policy impact.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Robot-Assisted Surgery vs Robotic Stereotactic Body Radiotherapy in Prostate Cancer: A Cost-Utility Analysis
7 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Clinique Ambroise Paré

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago